Hidradenocarcinoma in a Crohn's patient on ustekinumab: A case report.
SAGE Open Med Case Rep
; 12: 2050313X241254732, 2024.
Article
in En
| MEDLINE
| ID: mdl-39071199
ABSTRACT
Hidradenocarcinoma is a locally aggressive malignancy of the sweat glands, most commonly found on the head, neck, and upper body. Although rare, it has been seen in patients with hidradenitis supparativa, who have an increased risk of non-melanoma skin cancers. Ustekinumab, a biologic agent used to treat inflammatory bowel disease, has been associated with development of cancer in some patients. We present a case of a 36-year-old female with hidradenitis supparativa and Crohn's disease who developed hidradenocarcinoma in setting of ustekinumab use, demonstrating the need for further study of the relationship between biologic therapy and malignancy.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
SAGE Open Med Case Rep
Year:
2024
Type:
Article
Affiliation country:
United States